Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 26.10.2021 at 12:00 PM CEST
Settings

Settings

Goto Application

1. WO2021204060 - COMBINATIONS OF BCL-2/BCL-XL INHIBITORS AND RELATED USES

Publication Number WO/2021/204060
Publication Date 14.10.2021
International Application No. PCT/CN2021/084970
International Filing Date 01.04.2021
IPC
A61K 31/675 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
66Phosphorus compounds
675having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
A61K 31/407 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
407condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine
A61K 31/337 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
337having four-membered rings, e.g. taxol
A61P 35/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
A61P 35/04 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
04specific for metastasis
Applicants
  • ASCENTAGE PHARMA (SUZHOU) CO., LTD. [CN]/[CN]
  • ASCENTAGE PHARMA GROUP CORP LIMITED [CN]/[CN]
Inventors
  • ZHAI, Yifan
  • YANG, Dajun
Agents
  • KING & WOOD MALLESONS
Priority Data
202110344288.431.03.2021CN
PCT/CN2020/08414510.04.2020CN
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) COMBINATIONS OF BCL-2/BCL-XL INHIBITORS AND RELATED USES
(FR) COMBINAISONS D'INHIBITEURS DE BCL-2/BCL-XL ET UTILISATIONS ASSOCIÉES
Abstract
(EN)
The present disclosure relates to combinations of Compound No. 1 or a pharmaceutically acceptable salt thereof and at least one additional therapeutic agent. The present disclosure also relates to methods of treating or preventing a disease via administering to subjects in need thereof Compound No. 1 or a pharmaceutically acceptable salt thereof and at least one additional therapeutic agent.
(FR)
La présente invention concerne des combinaisons du composé n° 1 ou d'un sel pharmaceutiquement acceptable de celui-ci et d'au moins un agent thérapeutique supplémentaire. La présente invention concerne également des méthodes de traitement ou de prévention d'une maladie par l'administration à des sujets en ayant besoin dudit composé n° 1 ou d'un sel pharmaceutiquement acceptable de celui-ci et d'au moins un agent thérapeutique supplémentaire.
Related patent documents
EP2021754882This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
Latest bibliographic data on file with the International Bureau